Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Nature Communications
|
January 27, 2019
CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ
Jiao Fan, Lifeng Liu, Qingyan Liu, et al.
Cell Death & Disease
|
February 9, 2024
Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission
Ya-Wen Guo, Lei Zhu, Yan-Ting Duan, et al.
Journal of Hazardous Materials
|
November 22, 2021
Corrigendum to "TCDD-induced antagonism of MEHP-mediated migration and invasion partly involves aryl hydrocarbon receptor in MCF7 breast cancer cells" [J. Hazard. Mater. 398 (2020) 122869]
Anqi Shan, Ling Leng, Jing Li, et al.
Journal of Hazardous Materials
|
October 8, 2020
TCDD-induced antagonism of MEHP-mediated migration and invasion partly involves aryl hydrocarbon receptor in MCF7 breast cancer cells
Anqi Shan, Ling Leng, Jing Li, et al.
Molecular Medicine Reports
|
April 26, 2017
Associations of maternal PLA2G4C and PLA2G4D polymorphisms with the risk of spontaneous preterm birth in a Chinese population
Guang-Jian Liu, Jian-Rong He, Ya-Shu Kuang, et al.
Cell Research
|
April 30, 2014
CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation
Luo Zhang, Yiwu Wang, Fengjun Xiao, et al.
Advanced Healthcare Materials
|
March 29, 2024
Engineered Luminescent Oncolytic Vaccinia Virus Activation of Photodynamic-Immune Combination Therapy for Colorectal Cancer
Lu-Yi Ye, Yi-Shu Li, Tong Ge, et al.
Journal of Clinical Laboratory Analysis
|
February 19, 2017
Maternal IGF1 and IGF1R polymorphisms and the risk of spontaneous preterm birth
Jian-Rong He, Yu-Mian Lai, Hui-Hui Liu, et al.
Signal Transduction and Targeted Therapy
|
October 12, 2025
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study
Ru Jia, Hai-Yan Si, Meng-Jiao Fan, et al.
Cancer Communications (London, England)
|
April 20, 2026
First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Ru Jia, Yan-Rong Wang, Fang-Fang Liu, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Nature Communications
|
January 27, 2019
CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ
Jiao Fan, Lifeng Liu, Qingyan Liu, et al.
Cell Death & Disease
|
February 9, 2024
Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission
Ya-Wen Guo, Lei Zhu, Yan-Ting Duan, et al.
Journal of Hazardous Materials
|
November 22, 2021
Corrigendum to "TCDD-induced antagonism of MEHP-mediated migration and invasion partly involves aryl hydrocarbon receptor in MCF7 breast cancer cells" [J. Hazard. Mater. 398 (2020) 122869]
Anqi Shan, Ling Leng, Jing Li, et al.
Journal of Hazardous Materials
|
October 8, 2020
TCDD-induced antagonism of MEHP-mediated migration and invasion partly involves aryl hydrocarbon receptor in MCF7 breast cancer cells
Anqi Shan, Ling Leng, Jing Li, et al.
Molecular Medicine Reports
|
April 26, 2017
Associations of maternal PLA2G4C and PLA2G4D polymorphisms with the risk of spontaneous preterm birth in a Chinese population
Guang-Jian Liu, Jian-Rong He, Ya-Shu Kuang, et al.
Cell Research
|
April 30, 2014
CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation
Luo Zhang, Yiwu Wang, Fengjun Xiao, et al.
Advanced Healthcare Materials
|
March 29, 2024
Engineered Luminescent Oncolytic Vaccinia Virus Activation of Photodynamic-Immune Combination Therapy for Colorectal Cancer
Lu-Yi Ye, Yi-Shu Li, Tong Ge, et al.
Journal of Clinical Laboratory Analysis
|
February 19, 2017
Maternal IGF1 and IGF1R polymorphisms and the risk of spontaneous preterm birth
Jian-Rong He, Yu-Mian Lai, Hui-Hui Liu, et al.
Signal Transduction and Targeted Therapy
|
October 12, 2025
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study
Ru Jia, Hai-Yan Si, Meng-Jiao Fan, et al.
Cancer Communications (London, England)
|
April 20, 2026
First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Ru Jia, Yan-Rong Wang, Fang-Fang Liu, et al.
Page
of 10